Results 11 - 20 of 218 : Previous 1 2 3 4 5 6 7 8 9 Next
Same great fundamentals, new low price!
What to Do When the Dow Hits 12,000
Has a new bull market started?
Mylan's integrating well.
Biogen reports a third case of a deadly brain disorder.
Can You Defend Your Portfolio in One Fell Swoop?
A new index aims to track defensive giants.
3 Stocks Bucking the Downtrend
Sorting a real growth story from a flash in the pan.
You know it's coming.
Biogen Has Growth in all the Wrong Places
The company needs more Tysabri patients.
Novartis Is Taking the Road Less Traveled
Diversification should pay off for this pharma giant.
Get 'em while they're hot (and under bought).
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK